Ong J, Kerr D I, Abbenante J, Prager R H
Department of Anaesthesia and Intensive Care, University of Adelaide, Australia.
Eur J Pharmacol. 1991 Dec 3;205(3):319-22. doi: 10.1016/0014-2999(91)90918-g.
A new series of GABAB receptor antagonists, based on short-chain baclofen analogues has been investigated. In guinea-pig isolated ileal preparations, the GABAB receptor-mediated, baclofen-induced depression of cholinergic twitch responses was reversibly and competitively antagonised by the short-chain baclofen analogues 3-amino-3-(p-chlorophenyl)propionic acid (apparent pA2 = 3.5), 2-amino-2-(p-chlorophenyl)ethanephosphonic acid (apparent pA2 = 3.8), and 2-amino-2-(p-chlorophenyl)ethanesulphonic acid apparent pA2 = 4.0). The corresponding des-chloro analogues were all less active. These compounds represent another class of GABAB receptor antagonists which may cross the blood-brain barrier.
已对基于短链巴氯芬类似物的一系列新型GABAB受体拮抗剂进行了研究。在豚鼠离体回肠制备物中,短链巴氯芬类似物3-氨基-3-(对氯苯基)丙酸(表观pA2 = 3.5)、2-氨基-2-(对氯苯基)乙烷膦酸(表观pA2 = 3.8)和2-氨基-2-(对氯苯基)乙烷磺酸(表观pA2 = 4.0)可对GABAB受体介导的、巴氯芬诱导的胆碱能抽搐反应抑制作用产生可逆性竞争性拮抗。相应的去氯类似物活性均较低。这些化合物代表了另一类可能穿过血脑屏障的GABAB受体拮抗剂。